LMR Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-506,832
| Closed | -$50.3M | – | 645 |
|
|
2019
Q3 | $50.3M | Sell |
506,832
-484,032
| -49% | -$46M | 2.49% | 9 |
|
|
2019
Q2 | $91.6M | Buy |
990,864
+459,200
| +86% | +$43.6M | 3.34% | 4 |
|
|
2019
Q1 | $50.2M | Buy |
+531,664
| New | +$46.5M | 2.56% | 6 |
|
|
2018
Q2 | – | Sell |
-9,026
| Closed | -$942K | – | 608 |
|
|
2018
Q1 | $942K | Hold |
9,026
| – | – | 0.1% | 189 |
|
|
2017
Q4 | $942K | Buy |
+9,026
| New | +$1.02M | 0.1% | 189 |
|
|
2017
Q3 | – | Sell |
-22,653
| Closed | -$2.94M | – | 687 |
|
|
2017
Q2 | $2.94M | Buy |
22,653
+4,202
| +23% | +$515K | 0.18% | 113 |
|
|
2017
Q1 | $2.3M | Buy |
18,451
+15,480
| +521% | +$1.85M | 0.22% | 74 |
|
|
2016
Q4 | $344K | Buy |
+2,971
| New | +$331K | 0.05% | 273 |
|
|
2016
Q3 | – | Sell |
-11,203
| Closed | -$1.1M | – | 605 |
|
|
2016
Q2 | $1.1M | Buy |
+11,203
| New | +$1.16M | 0.17% | 174 |
|
|
2016
Q1 | – | Sell |
-2,471
| Closed | -$296K | – | 452 |
|
|
2015
Q4 | $296K | Buy |
+2,471
| New | +$286K | 0.1% | 174 |
|
|
2015
Q3 | – | Sell |
-26,699
| Closed | -$3.09M | – | 624 |
|
|
2015
Q2 | $3.09M | Buy |
26,699
+9,467
| +55% | +$1.08M | 0.38% | 53 |
|
|
2015
Q1 | $1.99M | Sell |
17,232
-11,501
| -40% | -$1.37M | 0.27% | 99 |
|
|
2014
Q4 | $3.21M | Buy |
+28,733
| New | +$3.03M | 0.42% | 43 |
|
|
2014
Q3 | – | Sell |
-8,759
| Closed | -$752K | – | 585 |
|
|
2014
Q2 | $752K | Buy |
+8,759
| New | +$666K | 0.06% | 265 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
LMR Partners's CELG Position: Q4 2019 in Review
LMR Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 506,832 shares — an estimated $50.3M sold.
LMR Partners first reported a position in CELG in Q2 2014 and held it in 14 quarters. The position peaked at $91.6M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- LMR Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- LMR Partners sold 506,832 Celgene Corp shares in Q4 2019, an estimated $50.3M.
- LMR Partners first reported a position in Celgene Corp in Q2 2014 and held it in 14 quarters.
- LMR Partners's Celgene Corp position peaked at $91.6M in Q2 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on LMR Partners's 13F filing for Q4 2019, filed 14 Feb 2020.